Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity

Area of Science:

• Immunology
• Cell Biology

Background:

• Plasmacytoid dendritic cells (pDCs) are key immune cells linking innate and adaptive immunity.
• pDCs produce type 1 interferon (IFN-I) upon detecting viral nucleic acids via TLR7 and TLR9.
• They possess dual functions: antigen presentation to induce T cell responses and tolerogenic functions like Treg induction.

Purpose of the Study:

• To review the multifaceted roles of pDCs in modulating T cell responses.
• To elucidate the contribution of innate and adaptive pDC functions in autoimmunity.
• To address conflicting findings regarding pDC-induced T cell outcomes.

Main Methods:

• Literature review of studies on pDC functions in immunity and autoimmunity.
• Analysis of experimental data investigating pDC-mediated T cell differentiation, deletion, and anergy.
• Examination of the impact of IFN-I on immune cell recruitment and activation.

Main Results:

• pDCs can induce both immunogenic (e.g., cytotoxic CD8+ T cells) and tolerogenic (e.g., Treg differentiation) T cell responses.
• IFN-I produced by pDCs indirectly influences adaptive immunity by activating other immune cells.
• pDC functions in autoimmunity are context-dependent, varying with disease and experimental conditions.

Conclusions:

• Dissecting the precise in vivo role of pDC antigen presentation is challenging due to their complex interactions.
• pDCs exhibit a dynamic balance of immunogenic and tolerogenic functions crucial for immune homeostasis.
• Understanding these dual roles is vital for comprehending and potentially manipulating immune responses in autoimmune diseases.